APA (7th ed.) Citation

Steck, A. R., Mahar, B., Martin, J. Y., McElrath, T. J., Patrick F. Timmins, I., & Barlin, J. N. Efficacy of pembrolizumab in combination with bevacizumab and oral metronomic cyclophosphamide in the treatment of platinum resistant recurrent ovarian cancer: A retrospective observational study. Elsevier.

Chicago Style (17th ed.) Citation

Steck, Alexandra R., Barbara Mahar, Jovana Y. Martin, Timothy J. McElrath, III Patrick F. Timmins, and Joyce N. Barlin. Efficacy of Pembrolizumab in Combination with Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Platinum Resistant Recurrent Ovarian Cancer: A Retrospective Observational Study. Elsevier.

MLA (9th ed.) Citation

Steck, Alexandra R., et al. Efficacy of Pembrolizumab in Combination with Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Platinum Resistant Recurrent Ovarian Cancer: A Retrospective Observational Study. Elsevier.